These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35962305)
21. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Yang R; Yang S; Li R; Liu P; Qiao J; Zhang Y Reprod Biol Endocrinol; 2016 Oct; 14(1):67. PubMed ID: 27756332 [TBL] [Abstract][Full Text] [Related]
22. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome. Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531 [TBL] [Abstract][Full Text] [Related]
23. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of Chinese patent medicine Xiao Yao San in polycystic ovary syndrome: A systematic review and meta-analysis. Zhou X; Ma Q; Yan Z; Wang Y; Qin J; Tong T; Liang R; Li Y; Wang Y; Chen J J Ethnopharmacol; 2023 Sep; 313():116517. PubMed ID: 37105369 [TBL] [Abstract][Full Text] [Related]
25. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome. Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959 [TBL] [Abstract][Full Text] [Related]
26. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Chien YJ; Chang CY; Wu MY; Chen CH; Horng YS; Wu HC Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669954 [TBL] [Abstract][Full Text] [Related]
27. The effects of curcumin on anthropometric and cardiometabolic parameters of patients with metabolic related diseases: a systematic review and dose-effect meta-analysis of randomized controlled trials. Sun Z; Wei X; Bai J; Li W; Yang J; Deng Z; Wu M; Ying T; He G Crit Rev Food Sci Nutr; 2023; 63(28):9282-9298. PubMed ID: 35475714 [No Abstract] [Full Text] [Related]
28. The effects of behavioral intervention on anthropometric, clinical, and biochemical parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Xie M; Yang Y; Zhang J Front Endocrinol (Lausanne); 2024; 15():1297841. PubMed ID: 38481448 [TBL] [Abstract][Full Text] [Related]
29. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
30. Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis. Chen LL; Zheng JH Medicine (Baltimore); 2021 Jun; 100(24):e26289. PubMed ID: 34128863 [TBL] [Abstract][Full Text] [Related]
31. Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials. Yalle-Vásquez S; Osco-Rosales K; Nieto-Gutierrez W; Benites-Zapata V; Pérez-López FR; Alarcon-Ruiz CA Gynecol Endocrinol; 2022 Jul; 38(7):548-557. PubMed ID: 35612360 [TBL] [Abstract][Full Text] [Related]
32. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762 [TBL] [Abstract][Full Text] [Related]
33. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis. Zeng H; Zhang Y; Huang S; Wu J; Ren W; Zhou L; Huang L; Ye Y Front Endocrinol (Lausanne); 2023; 14():1223768. PubMed ID: 37635987 [TBL] [Abstract][Full Text] [Related]
34. Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Clinical Trials. Fan M; Li Y; Zhang S Medicine (Baltimore); 2016 Jan; 95(2):e2386. PubMed ID: 26765417 [TBL] [Abstract][Full Text] [Related]
35. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China. Wang L; Lv S; Li F; Yu X; Bai E; Yang X Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394 [No Abstract] [Full Text] [Related]
36. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Xia Y; Wang Y; Cui M; Su D Ann Palliat Med; 2021 Jun; 10(6):6425-6437. PubMed ID: 34237964 [TBL] [Abstract][Full Text] [Related]
38. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome. Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322 [TBL] [Abstract][Full Text] [Related]
39. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials. Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195 [TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Zhao H; Xing C; Zhang J; He B Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]